These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5328496)

  • 21. Results obtained in comparative radiographie, clinical and clinical-chemical studies in iocetamic acid (DRC 1201) and iopanoic acid.
    Hekster RE
    Radiol Clin Biol; 1968; 37(6):338-52. PubMed ID: 5714064
    [No Abstract]   [Full Text] [Related]  

  • 22. Contrast media in abdominal computed tomography. A double blind clinical trial comparing a non-ionic (iohexol) and an ionic (metrizoate) contrast medium.
    Skalpe IO; Ostensen HM
    Eur J Radiol; 1984 Feb; 4(1):74-5. PubMed ID: 6373261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Minor complications encountered in oral cholecystography].
    Djian A; Annonier C; Prouveur P
    J Radiol Electrol Med Nucl; 1975; 56(8-9):613-4. PubMed ID: 1185710
    [No Abstract]   [Full Text] [Related]  

  • 24. [How risky is it for you to get complications when using the biliary contrast media Bilivistan and Biligrafin forte?].
    Steinert R
    Tidsskr Nor Laegeforen; 1969 Dec; 89(23):1802-3. PubMed ID: 5374848
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of scopolamine in the prevention of accidents due to organic iodinated contrast media].
    Ottolenghi G; Gagna C
    Minerva Radiol; 1968; 13(1):89-97. PubMed ID: 5736388
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effectiveness of atropine in the prevention of accidents due to organic iodinated contrast media].
    Ottolenghi G; Gagna C
    Minerva Radiol; 1968; 13(1):98-107. PubMed ID: 5736389
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiovascular and blood chemical changes following the use of ioglycamide (bilivistan) in cholecysto- and cholangiography].
    Klemencic J; Kalitzsch J; Kark B
    Med Welt; 1971 Dec; 49():1969-70. PubMed ID: 5127506
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 29. Bilivistan--a new contrast medium for intravenous cholangiocystography. Preliminary report.
    Bell HD; Braband H
    Br J Radiol; 1966 Jan; 39(457):63-5. PubMed ID: 5902405
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complications and risks of cholanigocholecystography].
    Crespi Porro R
    Minerva Med; 1968 Sep; 59(74):3910-8. PubMed ID: 5679587
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholangiocholecystography with phlebocysis of large doses of contrast medium in glucose solution].
    Biolcati-Rinaldi A; Sgarbi E
    Arch Ital Mal Appar Dig; 1968; 35(2):161-81. PubMed ID: 5706408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study of the cardiocirculatory effects and systemic reactions of 4 contrast media used in cineangiocardiography].
    Manfroi WC; Hemb R; Hoeffel JC; Rios SR; de Azevedo DF; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1981 Jun; 36(6):417-21. PubMed ID: 7347174
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholegraphy; the new contrast medium biligrafin.
    OESER H; FROMMHOLD W
    Acta radiol; 1955 May; 43(5):355-68. PubMed ID: 14398432
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pulmonary edema after administration of peroral biliary contrast media].
    Scheinert H; Torjussen B
    Tidsskr Nor Laegeforen; 1985 Mar; 105(9-10):674-6. PubMed ID: 3992559
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the diagnosis of the duodenal ulcer in oral cholecystography (author's transl)].
    Antalík J
    Rontgenblatter; 1980 Feb; 33(2):87-90. PubMed ID: 7355263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary clinical studies with a new non-ionic contrast medium (Iopamidol) in intravenous pyelography].
    Miyakawa M; Yoshida O
    Hinyokika Kiyo; 1984 Mar; 30(3):431-5. PubMed ID: 6380240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous cholegraphy with biligram. Clinical pharmacology].
    Taenzer V; Herms HJ
    Fortschr Geb Rontgenstr Nuklearmed; 1971 Jan; 114(1):102-7. PubMed ID: 5099735
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contrast media laying in cholegraphy].
    Lindqvist M; Saltzman GF
    Nord Med; 1970 Oct; 84(41):1313. PubMed ID: 5469338
    [No Abstract]   [Full Text] [Related]  

  • 39. [Differences between Bilivistan and Biligrafin in intravenous cholangiocholecystography].
    Gollmann G; Gasperlmair J; Hammer B
    Med Welt; 1967 Feb; 8():442-5. PubMed ID: 6044566
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of adverse reactions to contrast media in urography and cholecystography].
    Schindler G
    Rontgenpraxis; 1982 May; 35(5):161-5. PubMed ID: 7089722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.